Uncovering Advanced Enzyme Technologies And 2 Other Promising Indian Small Caps

In This Article:

Over the last 7 days, the Indian market has dropped 1.1%, but it remains up 40% over the past year with earnings expected to grow by 17% per annum. In this dynamic environment, identifying promising small-cap stocks like Advanced Enzyme Technologies can be key to capitalizing on growth opportunities.

Top 10 Undiscovered Gems With Strong Fundamentals In India

Name

Debt To Equity

Revenue Growth

Earnings Growth

Health Rating

Bharat Rasayan

8.15%

0.10%

-7.93%

★★★★★★

Om Infra

13.99%

43.36%

27.64%

★★★★★☆

Indo Tech Transformers

2.30%

22.05%

60.31%

★★★★★☆

Ingersoll-Rand (India)

1.05%

14.88%

27.54%

★★★★★☆

Genesys International

12.13%

15.75%

36.33%

★★★★★☆

BLS E-Services

1.67%

15.04%

51.58%

★★★★★☆

Monarch Networth Capital

32.66%

31.02%

50.24%

★★★★☆☆

Sky Gold

127.01%

22.02%

48.03%

★★★★☆☆

Sanstar

50.30%

-8.41%

48.59%

★★★★☆☆

Rir Power Electronics

54.23%

16.42%

34.78%

★★★★☆☆

Click here to see the full list of 481 stocks from our Indian Undiscovered Gems With Strong Fundamentals screener.

Here we highlight a subset of our preferred stocks from the screener.

Advanced Enzyme Technologies

Simply Wall St Value Rating: ★★★★★★

Overview: Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally with a market cap of ?57.14 billion.

Operations: Advanced Enzyme Technologies generates revenue primarily from the manufacturing and sales of enzymes, amounting to ?6.31 billion. The company's financial performance includes a notable gross profit margin of 55%.

Advanced Enzyme Technologies has shown promising growth, with earnings rising 18.9% over the past year, outpacing the Chemicals industry’s 10.7%. The company’s debt to equity ratio improved from 5% to 3.5% in five years, and it holds more cash than its total debt. Recent Q1 results reported sales of ?1,545 million and net income of ?341 million compared to ?288 million a year ago. Earnings per share increased from ?2.58 to ?3.05, reflecting solid performance despite insider selling in the last quarter.

NSEI:ADVENZYMES Debt to Equity as at Sep 2024
NSEI:ADVENZYMES Debt to Equity as at Sep 2024

Gokul Agro Resources

Simply Wall St Value Rating: ★★★★★☆

Overview: Gokul Agro Resources Limited engages in the manufacture and trading of edible and non-edible oils, meals, and other agro products in India, with a market cap of ?44.60 billion.

Operations: The primary revenue stream for Gokul Agro Resources Limited is from agro-based commodities, amounting to ?156.80 billion. The company has a market cap of ?44.60 billion.